Two Sigma Investments, LP Connect Biopharma Holdings LTD Transaction History

Two Sigma Investments, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.01 - $1.74 $606 - $1,044	-600 Reduced 5.26%	10,805 $18,000
Q4 2023 Feb 14, 2024	SELL	$0.7 - $2.06 $4,069 - $11,976	-5,814 Reduced 33.77%	11,405 $13,000
Q3 2023 Nov 14, 2023	SELL	$0.65 - $1.18 $4,138 - $7,513	-6,367 Reduced 26.99%	17,219 $14,000
Q2 2023 Aug 14, 2023	BUY	$1.01 - $1.25 $23,821 - $29,482	23,586 New	23,586 $26,000
Q2 2022 Aug 15, 2022	BUY	$0.56 - $3.25 $15,688 - $91,052	28,016 New	28,016 $24,000
Q1 2022 May 16, 2022	SELL	$2.46 - $5.92 $38,454 - $92,541	-15,632 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.26 - $23.33 $66,592 - $364,694	15,632 New	15,632 $81,000

3.03M

Ticker CNTB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,015,800
Market Cap $55.6M
Description
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.